• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Laboratory findings that predict a poor prognosis in COVID-19 patients with diabetes: A meta-analysis.

作者信息

Lagunas-Rangel Francisco Alejandro, Chávez-Valencia Venice

机构信息

Department of Genetics and Molecular Biology, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (CINVESTAV), Mexico City, Mexico.

Department of Nephrology, Hospital General Regional No. 1, Instituto Mexicano del Seguro Social, Morelia, Michoacán, Mexico.

出版信息

Endocrinol Diabetes Nutr. 2021 Aug-Sep;68(7):520-522. doi: 10.1016/j.endinu.2020.07.002. Epub 2020 Sep 12.

DOI:10.1016/j.endinu.2020.07.002
PMID:34632291
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7486817/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/301b/7486817/3641f25ec106/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/301b/7486817/3641f25ec106/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/301b/7486817/3641f25ec106/gr1_lrg.jpg

相似文献

1
Laboratory findings that predict a poor prognosis in COVID-19 patients with diabetes: A meta-analysis.预测2型糖尿病合并新型冠状病毒肺炎患者预后不良的实验室检查结果：一项荟萃分析。
Endocrinol Diabetes Nutr. 2021 Aug-Sep;68(7):520-522. doi: 10.1016/j.endinu.2020.07.002. Epub 2020 Sep 12.
2
Clinical characteristics, laboratory abnormalities and CT findings of COVID-19 patients and risk factors of severe disease: a systematic review and meta-analysis.COVID-19 患者的临床特征、实验室异常和 CT 表现及重症危险因素的系统评价和荟萃分析。
Ann Palliat Med. 2021 Feb;10(2):1928-1949. doi: 10.21037/apm-20-1863. Epub 2021 Jan 27.
3
Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19-systematic review, meta-analysis, and meta-regression.脑血管和心血管疾病对新冠病毒疾病死亡率及严重程度的影响——系统评价、荟萃分析和荟萃回归
J Stroke Cerebrovasc Dis. 2020 Aug;29(8):104949. doi: 10.1016/j.jstrokecerebrovasdis.2020.104949. Epub 2020 May 14.
4
Prognostic Value of Leucocyte to High-Density Lipoprotein-Cholesterol Ratios in COVID-19 Patients and the Diabetes Subgroup.白细胞与高密度脂蛋白胆固醇比值对 COVID-19 患者及糖尿病亚组的预后价值。
Front Endocrinol (Lausanne). 2021 Sep 13;12:727419. doi: 10.3389/fendo.2021.727419. eCollection 2021.
5
Prevalence and impact of diabetes and cardiovascular disease on clinical outcome among patients with COVID-19 in Bangladesh.糖尿病和心血管疾病在孟加拉国新冠肺炎患者中的患病率及其对临床结局的影响。
Diabetes Metab Syndr. 2021 May-Jun;15(3):1009-1016. doi: 10.1016/j.dsx.2021.05.005. Epub 2021 May 8.
6
Clinical and radiological changes of hospitalised patients with COVID-19 pneumonia from disease onset to acute exacerbation: a multicentre paired cohort study.新型冠状病毒肺炎住院患者从发病到急性加重期的临床及影像学变化：一项多中心配对队列研究
Eur Radiol. 2020 Oct;30(10):5702-5708. doi: 10.1007/s00330-020-06916-4. Epub 2020 May 8.
7
Major Characteristics of Severity and Mortality in Diabetic Patients With COVID-19 and Establishment of Severity Risk Score.2019冠状病毒病糖尿病患者的严重程度和死亡率主要特征及严重程度风险评分的建立
Front Med (Lausanne). 2021 Jun 7;8:655604. doi: 10.3389/fmed.2021.655604. eCollection 2021.
8
Correlations of Clinical and Laboratory Characteristics of COVID-19: A Systematic Review and Meta-Analysis.新型冠状病毒肺炎的临床与实验室特征相关性的系统评价和荟萃分析。
Int J Environ Res Public Health. 2020 Jul 13;17(14):5026. doi: 10.3390/ijerph17145026.
9
Risk Factors for Poor Outcomes of Diabetes Patients With COVID-19: A Single-Center, Retrospective Study in Early Outbreak in China.中国新冠肺炎疫情早期单中心回顾性研究：糖尿病合并 COVID-19 患者不良预后的危险因素。
Front Endocrinol (Lausanne). 2020 Sep 24;11:571037. doi: 10.3389/fendo.2020.571037. eCollection 2020.
10
Clinical outcomes of hospitalized COVID-19 patients with renal injury: a multi-hospital observational study from Wuhan.新冠肺炎合并肾损伤住院患者的临床转归：一项来自武汉的多中心观察性研究。
Sci Rep. 2021 Jul 26;11(1):15205. doi: 10.1038/s41598-021-94570-1.

引用本文的文献

1
Maximum insulin dose in patients admitted to the intensive care units with severe COVID-19 in the "Cross ICU Searchable Information System" study: A multicenter retrospective cohort study.“跨重症监护病房可检索信息系统”研究中重症新型冠状病毒肺炎（COVID-19）患者入住重症监护病房时的最大胰岛素剂量：一项多中心回顾性队列研究
J Diabetes Investig. 2025 Mar;16(3):555-560. doi: 10.1111/jdi.14380. Epub 2024 Dec 10.
2
Increased Insulin Requirements in Severe Cases of Covid-19 are Higher Than in Moderate Cases.新冠重症病例中胰岛素需求的增加高于中症病例。
Diabetes Metab Syndr Obes. 2024 Oct 10;17:3727-3733. doi: 10.2147/DMSO.S480598. eCollection 2024.
3

本文引用的文献

1
Clinical analysis of risk factors for severe COVID-19 patients with type 2 diabetes.2 型糖尿病重症 COVID-19 患者的危险因素临床分析。
J Diabetes Complications. 2020 Oct;34(10):107666. doi: 10.1016/j.jdiacomp.2020.107666. Epub 2020 Jun 29.
2
Prognostic factors in patients with diabetes hospitalized for COVID-19: Findings from the CORONADO study and other recent reports.COVID-19 住院糖尿病患者的预后因素：CORONADO 研究及其他近期报告的结果。
Diabetes Metab. 2020 Sep;46(4):265-271. doi: 10.1016/j.diabet.2020.05.008. Epub 2020 May 21.
3
Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study.
Association of serum amyloid A and prognosis in people with diabetes and COVID-19: A retrospective cohort study.
血清淀粉样蛋白 A 与 COVID-19 合并糖尿病患者预后的相关性：一项回顾性队列研究。
J Diabetes Investig. 2024 Jan;15(1):44-51. doi: 10.1111/jdi.14118. Epub 2023 Nov 29.
4
On the Origin of Neutrophil Extracellular Traps in COVID-19.新冠病毒感染中中性粒细胞胞外诱捕网的起源
Front Immunol. 2022 Mar 11;13:821007. doi: 10.3389/fimmu.2022.821007. eCollection 2022.
5
Diabetes, obesity, hypertension and risk of severe COVID-19: a protocol for systematic review and meta-analysis.糖尿病、肥胖症、高血压与重症新型冠状病毒肺炎风险：一项系统评价与荟萃分析方案
BMJ Open. 2021 Nov 26;11(11):e051711. doi: 10.1136/bmjopen-2021-051711.
6
What do we know about the antibody responses to SARS-CoV-2?我们对针对 SARS-CoV-2 的抗体反应了解多少？
Immunobiology. 2021 Mar;226(2):152054. doi: 10.1016/j.imbio.2021.152054. Epub 2021 Jan 23.
中国武汉 COVID-19 合并糖尿病患者的临床特征和死亡危险因素：一项两中心回顾性研究。
Diabetes Care. 2020 Jul;43(7):1382-1391. doi: 10.2337/dc20-0598. Epub 2020 May 14.
4
COVID-19 and diabetes mellitus: An unholy interaction of two pandemics.2019冠状病毒病与糖尿病：两种大流行病的不良相互作用。
Diabetes Metab Syndr. 2020 Jul-Aug;14(4):513-517. doi: 10.1016/j.dsx.2020.04.049. Epub 2020 May 6.
5
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes.COVID-19 合并 2 型糖尿病患者的血糖控制与结局的相关性。
Cell Metab. 2020 Jun 2;31(6):1068-1077.e3. doi: 10.1016/j.cmet.2020.04.021. Epub 2020 May 1.
6
CLINICAL CHARACTERISTICS OF 28 PATIENTS WITH DIABETES AND COVID-19 IN WUHAN, CHINA.中国武汉 28 例糖尿病合并 COVID-19 患者的临床特征。
Endocr Pract. 2020 Jun 2;26(6):668-674. doi: 10.4158/EP-2020-0108. Epub 2020 May 1.
7
Clinical characteristics and outcomes of patients with severe covid-19 with diabetes.伴有糖尿病的重症 COVID-19 患者的临床特征和结局。
BMJ Open Diabetes Res Care. 2020 Apr;8(1). doi: 10.1136/bmjdrc-2020-001343.
8
COVID-19 and diabetes: Knowledge in progress.新型冠状病毒肺炎与糖尿病：知识在不断更新。
Diabetes Res Clin Pract. 2020 Apr;162:108142. doi: 10.1016/j.diabres.2020.108142. Epub 2020 Apr 9.
9
Diabetes is a risk factor for the progression and prognosis of COVID-19.糖尿病是新冠病毒疾病（COVID-19）进展和预后的一个风险因素。
Diabetes Metab Res Rev. 2020 Oct;36(7):e3319. doi: 10.1002/dmrr.3319. Epub 2020 Apr 7.
10
Estimating the mean and variance from the median, range, and the size of a sample.根据中位数、极差和样本量估计均值和方差。
BMC Med Res Methodol. 2005 Apr 20;5:13. doi: 10.1186/1471-2288-5-13.